We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+2.16%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+377.38%
AUM
$881M
AUM Growth
-$121M
Cap. Flow
-$139M
Cap. Flow %
-15.77%
Top 10 Hldgs %
39.5%
Holding
4,106
New
974
Increased
850
Reduced
839
Closed
1,374

Sector Composition

Rank Sector Weight
1 Technology 2.15%
2 Energy 2.14%
3 Industrials 2.11%
4 Financials 2.11%
5 Consumer Discretionary 1.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRVG
2126
trivago
TRVG
$382M
$4K ﹤0.01%
37
-436
-92% -$38.2K
VNRX icon
2127
VolitionRx Ltd
VNRX
$9.44M
$4K ﹤0.01%
61
+36
+144% +$2.6K
VOYA icon
2128
Voya Financial
VOYA
$9.03B
$4K ﹤0.01%
100
VTRS icon
2129
Viatris
VTRS
$20.4B
$4K ﹤0.01%
+100
New +$3.84K
WULF icon
2130
TeraWulf
WULF
$9.39B
$4K ﹤0.01%
400
+397
+13,233% +$3.4K
LFWD icon
2131
ReWalk Robotics
LFWD
$19.9M
$4K ﹤0.01%
+1
New +$3.26K
CNH
2132
CNH Industrial
CNH
$13.8B
$4K ﹤0.01%
364
-832
-70% -$7.85K
FLG
2133
Flagstar Bank National Association
FLG
$5.95B
$4K ﹤0.01%
108
-526
-83% -$20.9K
ITCI
2134
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$4K ﹤0.01%
+340
New +$3.94K
FBMS
2135
DELISTED
The First Bancshares, Inc.
FBMS
$4K ﹤0.01%
+148
New +$4.15K
RCM
2136
DELISTED
R1 RCM Inc. Common Stock
RCM
$4K ﹤0.01%
+1,000
New +$3.67K
DXYN
2137
DELISTED
Dixie Group Inc
DXYN
$4K ﹤0.01%
+1,011
New +$4.09K
VBIV
2138
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$4K ﹤0.01%
23
+16
+229% +$2.16K
BPTH
2139
DELISTED
Bio-Path Holdings Inc
BPTH
$4K ﹤0.01%
3
-29
-91% -$60.8K
ONCT
2140
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$4K ﹤0.01%
5
-1
-17% -$613
AVTA
2141
DELISTED
Avantax, Inc. Common Stock
AVTA
$4K ﹤0.01%
201
-935
-82% -$18.5K
AJRD
2142
DELISTED
Aerojet Rocketdyne Holdings
AJRD
$4K ﹤0.01%
200
+100
+100% +$2.15K
SNMP
2143
DELISTED
Evolve Transition Infrastructure LP
SNMP
$4K ﹤0.01%
+10
New +$4.16K
APTO
2144
DELISTED
Aptose Biosciences, Inc.
APTO
$4K ﹤0.01%
+6
New +$2.89K
DDF
2145
DELISTED
Delaware Investments Dividend & Income Fund, Inc.
DDF
$4K ﹤0.01%
+352
New +$3.66K
LCI
2146
DELISTED
Lannett Company, Inc.
LCI
$4K ﹤0.01%
+50
New +$4.36K
GFED
2147
DELISTED
Guaranty Federal Bancshares In
GFED
$4K ﹤0.01%
180
+170
+1,700% +$3.39K
MRLN
2148
DELISTED
Marlin Business Services Corp
MRLN
$4K ﹤0.01%
+143
New +$3.6K
USCR
2149
DELISTED
U S Concrete, Inc.
USCR
$4K ﹤0.01%
+47
New +$3.19K
DFVS
2150
DELISTED
iPath US Treasury 5-year Bear ETN
DFVS
$4K ﹤0.01%
123
-77
-39% -$2.22K

Similar funds

Tower Research Capital (TRC)'s Q2 2017 Portfolio in Review

As of Q2 2017, Tower Research Capital (TRC) held 4,106 positions worth $881M, down 12% from $1B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Tower Research Capital (TRC) withdrew a net $139M in Q2 2017, closing 1,374 positions and reducing 839 holdings. Its most notable exit was State Street SPDR S&P Retail ETF, an estimated $5.29M position sold in full.

By sector, the portfolio is most concentrated in Technology at 2.1% of assets, up from 1.5% a quarter earlier, followed by Energy and Industrials.

Against the trend, Tower Research Capital (TRC) opened a new position in State Street Consumer Discretionary Select Sector SPDR ETF worth $17.2M.

  • Tower Research Capital (TRC)'s largest Q2 2017 buy was State Street Consumer Discretionary Select Sector SPDR ETF: 382,942 shares worth $17.2M.
  • Tower Research Capital (TRC) added most to iShares MSCI Emerging Markets ETF in Q2 2017, an estimated $60M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $152M.
  • Tower Research Capital (TRC) fully exited State Street SPDR S&P Retail ETF in Q2 2017, selling an estimated $5.29M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 40% of its $881M portfolio in Q2 2017.
  • Tower Research Capital (TRC) opened 974 new positions and closed 1,374 in Q2 2017.
  • Tower Research Capital (TRC)'s portfolio value fell 12% quarter-over-quarter to $881M.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2017, filed 15 Aug 2017.